Search Within

Charles Rudin

Formats
  1. Journal Article (244)
  2. Meeting Abstract (223)
  3. Review (11)
  4. Editorial (10)
  5. Book Section (3)
  6. Guidelines (2)
  7. Research Letter (2)
  8. Correspondence (1)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (496)
  2. Center for Molecular Imaging and Biotechnology (CMIB) (496)
  3. Department of Medicine (496)
  4. GSK Faculty (496)
  5. Solid Tumor Oncology Division (496)
  6. Thoracic Oncology (496)

More Groups

People
  1. Mark Kris (100)
  2. Natasha Rekhtman (96)
  3. Marc Ladanyi (93)
  4. Gregory Riely (76)
  5. Bob Li (72)
  6. Elisa De Stanchina (70)

More People

Years
  1. 2025 (19)
  2. 2024 (48)
  3. 2023 (43)
  4. 2022 (59)
  5. 2021 (52)
  6. 2020 (50)

More Years

Publications
  1. Journal of Clinical Oncology (83)
  2. Journal of Thoracic Oncology (79)
  3. Clinical Cancer Research (34)
  4. Cancer Research (31)
  5. Annals of Oncology (30)
  6. Cancer Discovery (15)

More Publications

Publishers
  1. Elsevier Inc. (105)
  2. American Society of Clinical Oncology (93)
  3. American Association for Cancer Research (87)
  4. Nature Publishing Group (45)
  5. Oxford University Press (40)
  6. Cell Press (28)

More Publishers

Results (496)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Identifying HER2 mutation, amplification, and HER2 protein overexpression as therapeutic targets in lung cancers
    Meeting Abstract

    Li, B. T.; Zheng, T.; Ni, A.; Hellmann, M. D.; Jordan, E.; Barron, D.; Smyth, L. M.; Solit, D. B.; Zehir, A.; Ross, D. S.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Next generation sequencing (NGS) in lung adenocarcinoma (LA) as a guide to treatment selection
    Meeting Abstract

    Jordan, E.; Barron, D.; Schultz, N.; Chakravarty, D.; Kris, M. G.; Rudin, C. M.; Li, B. T.; Yu, H. A.; Drilon, A. E.; Rusch, V. W.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Updated results of phase 1b study of tarextumab (TRXT, anti-Notch2/3) in combination with etoposide and platinum (EP) in patients (pts) with untreated extensive-stage small-cell lung cancer (ED-SCLC)
    Meeting Abstract

    Chiang, A. C.; Rudin, C. M.; Spira, A. I.; Jotte, R. M.; Gadgeel, S. M.; Mita, A. C.; Hart, L. L.; Gluck, W. L.; Liu, S. V.; Kapoun, A. M.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Missing the mark in FGFR1-amplified squamous cell cancer of the lung
    Journal Article

    Paik, P. K.; Rudin, C. M.
    Cancer (2016)

    Fulltext@MSK | Save
  • A phase 1/2 trial of a monoclonal antibody targeting fucosyl GM1 in relapsed/refractory small cell lung cancer (SCLC): Safety and preliminary efficacy
    Meeting Abstract

    Chu, Q. S. C.; Markman, B.; Leighl, N.; Krug, L.; Rudin, C.; Lathers, D.; Basciano, P.; Fracasso, P. M.; Kollia, G.; Phillips, P.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Preliminary safety and clinical activity of erlotinib plus atezolizumab from a Phase Ib study in advanced NSCLC
    Meeting Abstract

    Ma, B. B. Y.; Rudin, C. M.; Cervantes, A.; Dowlati, A.; Costa, D.; Schmid, P.; Heist, R.; Villaflor, V. M.; Sarkar, I.; Huseni, M. A.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Phase I clinical study of intratumoral injection of oncolytic Clostridium novyi-NT spores in patients with advanced cancers
    Meeting Abstract

    Janku, F.; Murthy, R.; Wang-Gillam, A.; Shepard, D.; Helgason, T.; Henry, T.; Rudin, C.; Huang, S.; Sakamuri, D.; Solomon, S.; more...
    European Journal of Cancer (2016)

    Fulltext@MSK | Save
  • SLFN11 is necessary for single agent sensitivity to talazoparib, a potent PARP inhibitor, but not for radiosensitization in small cell lung cancer (SCLC) cell lines and patient-derived xenografts (PDX)
    Meeting Abstract

    Lok, B. H.; Feng, Y.; Gardner, E. E.; Yu, G. K.; Ru, Y. K.; Riaz, N.; deStanchina, E.; Powell, S. N.; Shen, Y. J.; Poirier, J. T.; more...
    International Journal of Radiation Oncology, Biology, Physics (2016)

    Fulltext@MSK | Save
  • Cabozantinib in patients with advanced RET-rearranged non-small-cell lung cancer: an open-label, single-centre, phase 2, single-arm trial
    Journal Article

    Drilon, A.; Rekhtman, N.; Arcila, M.; Wang, L.; Ni, A.; Albano, M.; Van Voorthuysen, M.; Somwar, R.; Smith, R. S.; Montecalvo, J.; more...
    Lancet Oncology (2016)

    Fulltext@MSK | Save
  • Large cell neuroendocrine carcinoma of the lung: Clinico-pathologic features, treatment, and outcomes
    Journal Article

    Naidoo, J.; Santos-Zabala, M. L.; Iyriboz, T.; Woo, K. M.; Sima, C. S.; Fiore, J. J.; Kris, M. G.; Riely, G. J.; Lito, P.; Iqbal, A.; more...
    Clinical Lung Cancer (2016)

    Fulltext@MSK | Save